Skip to content

A prospective cohort study to improve the AccUracy of Referrals to the emerGency departmEnt of patieNts with chesT pain: to decrease the delay in acute coronary syndrome patients and rule out non-cardiac chest pain patients (URGENT)

A prospective cohort study to improve the AccUracy of Referrals to the emerGency departmEnt of patieNts with chesT pain: to decrease the delay in acute coronary syndrome patients and rule out non-cardiac chest pain patients (URGENT) - Improving the accuracy of referrals of patients with chest pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45470
Enrollment
500
Registered
2017-02-28
Start date
2017-04-18
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome hartattack

Interventions

None listed

Sponsors

Viecuri Medisch Centrum voor Noord-Limburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients with chest pain or other complaints suspect of acute coronary syndrome can be included in which the GP at the GP cooperation is in need of further diagnostics to come to a decision.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years. Patients in which a typical history and/or physical examination requires immediate referral; high suspicion of acute coronary syndrome. Patients in which an acute non-coronary diagnosis is suspected, e.g. pulmonary embolism, thoracic aortic dissection etc.

Design outcomes

Primary

MeasureTime frame
The main study point is a more accurate referral of patients with suspected ACS to the cardiac ED and thus the concordance of suspected ACS and the actual diagnosis. The prompt referral of ACS patients will also be assessed through evaluation of the delays in these patients. Both of these endpoints will be compared to the baseline registry that has been executed from 1st of September 2015 until 1st of March 2016.

Secondary

MeasureTime frame
The secondary study endpoint is MACE at 1 year follow-up. This is a combined endpoint of: 1. Mortality 2. Any ischemic cardiac event a. ST-elevated myocardial infarction b. Non ST-elevated myocardial infarction c. (Unstable) angina pectoris d. Percutaneous coronary intervention e. Coronary artery bypass graft surgery (CABG) f. Resuscitation

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)